EcoDrugPlus

Ensembl ID : ENSCHYG00000024033
Gene Symbol: -
Cross references: -
272 Possible Orthologues:

Ensembl ID : ENSCHYG00000012008
Gene Symbol: -
Cross references: -
401 Possible Orthologues:

Ensembl ID : ENSCHYG00000011123
Gene Symbol: -
Cross references: -
704 Possible Orthologues:

Ensembl ID : ENSCHYG00000009557
Gene Symbol: -
Cross references: -
317 Possible Orthologues:

Ensembl ID : ENSCHYG00000009547
Gene Symbol: -
Cross references: -
160 Possible Orthologues:

Ensembl ID : ENSCHYG00000009502
Gene Symbol: -
Cross references: -
166 Possible Orthologues:

Ensembl ID : ENSCHYG00000024253
Gene Symbol: -
Cross references: -
287 Possible Orthologues:

Ensembl ID : ENSCHYG00000024429
Gene Symbol: -
Cross references: -
171 Possible Orthologues:

Ensembl ID : ENSCHYG00000009474
Gene Symbol: -
Cross references: -
272 Possible Orthologues:

Ensembl ID : ENSCHYG00000000696
Gene Symbol: -
Cross references: -
106 Possible Orthologues:

Ensembl ID : ENSCHYG00000001645
Gene Symbol: -
Cross references: -
104 Possible Orthologues:

Ensembl ID : ENSCHYG00000002715
Gene Symbol: -
Cross references: -
261 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).